Your browser doesn't support javascript.
loading
Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL).
Mocciaro, Gabriele; Allison, Michael; Jenkins, Benjamin; Azzu, Vian; Huang-Doran, Isabel; Herrera-Marcos, Luis Vicente; Hall, Zoe; Murgia, Antonio; Susan, Davies; Frontini, Mattia; Vidal-Puig, Antonio; Koulman, Albert; Griffin, Julian L; Vacca, Michele.
Afiliación
  • Mocciaro G; University of Cambridge, Department of Biochemistry, Cambridge, CB2 1GA, United Kingdom; Roger Williams Institute of Hepatology, Foundation for Liver Research, London, SE5 9NT, United Kingdom.
  • Allison M; Addenbrooke's Hospital, Cambridge Biomedical Research Centre, Department of Medicine, United Kingdom.
  • Jenkins B; Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, Cambridge, CB2 0QQ, United Kingdom.
  • Azzu V; Addenbrooke's Hospital, Cambridge Biomedical Research Centre, Department of Medicine, United Kingdom; Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, Cambridge, CB2 0QQ, United Kingdom.
  • Huang-Doran I; Addenbrooke's Hospital, Cambridge Biomedical Research Centre, Department of Medicine, United Kingdom.
  • Herrera-Marcos LV; Department of Biochemistry and Molecular and Cellular Biology, Veterinary Faculty, University of Zaragoza, Zaragoza, 50013, Spain.
  • Hall Z; Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, SW7 2AZ, United Kingdom.
  • Murgia A; University of Cambridge, Department of Biochemistry, Cambridge, CB2 1GA, United Kingdom.
  • Susan D; Addenbrooke's Hospital, Cambridge Biomedical Research Centre, Department of Medicine, United Kingdom.
  • Frontini M; Faculty of Health and Life Sciences, Clinical and Biomedical Sciences, University of Exeter Medical School, RILD Building, Barrack Road, Exeter, EX2 5DW, United Kingdom.
  • Vidal-Puig A; Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, Cambridge, CB2 0QQ, United Kingdom.
  • Koulman A; Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, Cambridge, CB2 0QQ, United Kingdom. Electronic address: ak675@medschl.cam.ac.uk.
  • Griffin JL; University of Cambridge, Department of Biochemistry, Cambridge, CB2 1GA, United Kingdom; The Rowett Institute, Foresterhill Campus, University of Aberdeen, Aberdeen, AB25 2ZD, United Kingdom. Electronic address: jules.griffin@abdn.ac.uk.
  • Vacca M; University of Cambridge, Department of Biochemistry, Cambridge, CB2 1GA, United Kingdom; Roger Williams Institute of Hepatology, Foundation for Liver Research, London, SE5 9NT, United Kingdom; Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, Cambridge, CB2 0QQ, Unit
Mol Metab ; 73: 101728, 2023 07.
Article en En | MEDLINE | ID: mdl-37084865
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a la Insulina / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania